Jaime-Pérez, José Carlos <br/><br/>
Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.  [electronic resource] 

 -  Archives of medical research  Aug 2015 
 - 454-61 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-5487 
<br/><br/><label>Standard No.: </label>10.1016/j.arcmed.2015.07.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cohort Studies<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Lymphoma, Follicular--drug therapy<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Retrospective Studies<br/>Risk Factors<br/>Rituximab--administration & dosage<br/>Treatment Outcome<br/>Young Adult